CONTACT
INTRODUCTION
About Us
About PEBD
About IRIS
Research Overview
MEMBERS
Professor
Research Professor
Students
Alumni
Staff
RESEARCH
Projects
Publications
Invited Talks
BOARD
Notice
News
Gallery
Awards
Links
로고
INTRODUCTION
About Us
About PEBD
About IRIS
Research Overview
MEMBERS
Professor
Research Professor
Students
Alumni
Staff
RESEARCH
Projects
Publications
Invited Talks
BOARD
Notice
News
Gallery
Awards
Links
Home
INTRODUCTION
About Us
About PEBD
About IRIS
Research Overview
MEMBERS
Professor
Research Professor
Students
Alumni
Staff
RESEARCH
Projects
Publications
Invited Talks
BOARD
Notice
News
Gallery
Awards
Links
RESEARCH
Pharmaceutical Economics,
Big Data Analysis & Policy Lab
RESEARCH
INTRODUCTION
MEMBERS
RESEARCH
BOARD
Conference presentations
Projects
Publications
Invited Talks
Conference presentations
Articles
Conference proceedings
Conference presentations
Others
Total 168건
7 페이지
2022
78
"Treatment pathways of antiepileptics according to gender and age using common data model"
Kim MK, Lee EJ and Suh HS
, The 2022 Fall International Convention of The Pharmaceutical Society of Korea
Jeju, Korea. October 2022.
77
"Medication Treatment Pathways in Chronic Urticaria patients from electronic health record using OMOP-CDM (common data model)"
Oh J, Kim Y and Suh HS
, The 2022 Fall International Convention of The Pharmaceutical Society of Korea
Jeju, Korea. October 2022.
76
"The effect of expanding reimbursement criteria for G-csf injections In cancer patients; an interrupted time series"
Kim D, Choi K, Kim Y and Suh HS
, The 2022 Fall International Convention of The Pharmaceutical Society of Korea
Jeju, Korea. October 2022.
75
"HERMES: A Health Resources Econometric Analysis Tool"
Choi K, Park SJ, Han S, Kim S and Suh HS
, The 2022 Observational Health Data Sciences and Informatics
Washington DC, USA. October 2022.
74
"Productivity Loss and Indirect Costs Associated with Migraine and Probable Migraine in Korea"
Kim Y, Han S and Suh HS
, The 2022 International Society for Pharmacoeconomics and Outcomes Research
Washington, DC, USA. May 2022.
73
"Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis"
Lee K, Han S, Osipenko L and Suh HS
, The 2022 International Society for Pharmacoeconomics and Outcomes Research
Washington, DC, USA. May 2022.
72
"Economic Burden of Disease in Patients with Exudative Age-Related Macular Degeneration Using Common Data Model in South Korea"
Choi K, Park SJ, Han S and Suh HS
, The 2022 International Society for Pharmacoeconomics and Outcomes Research
Washington, DC, USA. May 2022.
71
"Real-World Effectiveness of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Population-Based Study in South Korea"
Kim S and Suh HS
, The 2022 International Society for Pharmacoeconomics and Outcomes Research
Washington, DC, USA. May 2022.
2021
70
"Clinical and economic benefit of changing The reimbursement criteria of statin in The primary prevention of cardiovascular events among diabetes patients in South Korea"
Kim S, Choi K, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
Jeonju. December 2021.
69
"Development of machine-learning models for predicting opioid intoxication using healthcare claims data"
LEE W, Kim Y, Choi K, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
Jeonju. December 2021.
68
"Anti-epileptic medication treatment pathways in adults from The electronic health record using The common data model"
Ju HE, Kim Y, Choi K, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
Jeonju. December 2021.
67
"Using machine learning models to predict End-Stage of Renal Disease (ESRD) risk in patients with type 2 diabetes diagnosed with chronic kidney disease (CKD)"
Cha JY, Park YM, Choi K, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
Seoul. December 2021.
66
"Development of The claims data-based liver cancer prediction model for patients in surveillance by using a machine learning"
Lee M, Choi K, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
Jeonju. December 2021.
65
"Economic burden of prescription opioid misuse in Korea"
Kim MR, Kim S, and Suh HS
, The 2021 Fall International Convention of The Pharmaceutical Society of Korea
December 2021.
64
"Venetoclax Combination Therapies Show Significant Improvements in Overall Survival and Remission in Treatment-Naïve Patients with AML who are Ineligible for Intensive ChemoTherapy: A Network Meta-Anal…"
Li X, Suh HS, Lachaine J, Schuh A, Pratz K, Betts K, Song J, Gu Ch, and Bui C
, The International Society for Pharmacoeconomics and Outcomes Research 24th Annual European Congress
Virtual Conference. November 30 – December 3, 2021.
처음
1
페이지
2
페이지
3
페이지
4
페이지
5
페이지
6
페이지
열린
7
페이지
8
페이지
9
페이지
10
페이지
다음
맨끝
검색
검색대상
제목
내용
제목+내용
글쓴이
글쓴이(코)
검색어
필수
검색
닫기
TOP